Breaking News Instant updates and real-time market news.

ITRM

Iterum Therapeutics

$8.55

(0.00%)

16:11
08/09/18
08/09
16:11
08/09/18
16:11

Iterum Therapeutics initiates SURE 1 Phase 3 clinical trial

Iterum Therapeutics announced its initiation of the first of three Phase 3 clinical trials. In this trial, known as Sulopenem for Resistant Enterobacteriaceae, or SURE, 1, oral sulopenem etzadroxil combined with probenecid in a bilayer tablet is compared to oral ciprofloxacin in women with uncomplicated urinary tract infections. Sulopenem is Iterum's lead compound and novel antibiotic for the treatment of gram-negative, multi-drug resistant infections.

  • 30

    Aug

  • 31

    Aug

ITRM Iterum Therapeutics
$8.55

(0.00%)

06/19/18
LEER
06/19/18
INITIATION
Target $18
LEER
Outperform
Iterum Therapeutics initiated with an Outperform at Leerink
Leerink analyst Ami Fadia initiated Iterum Therapeutics with an Outperform and $18 price target.
06/19/18
NEED
06/19/18
INITIATION
Target $20
NEED
Buy
Iterum Therapeutics initiated with a Buy at Needham
Needham analyst Alan Carr initiated Iterum Therapeutics with a Buy rating and a price target of $20, saying the company's sulopenem antibiotic addresses the unmet need for treatment of urinary tract infections. The analyst anticipates a phase 3 initiation for sulopenem in the second half of this year and a launch by the first quarter of 2021, estimating peak U.S. sales reaching $700M by 2033.
06/19/18
RBCM
06/19/18
INITIATION
Target $24
RBCM
Outperform
Iterum Therapeutics initiated with an Outperform at RBC Capital
RBC Capital analyst Gregory Renza initiated Iterum Therapeutics with an Outperform rating and a price target of $24. The analyst cites the company's sulopenem treatment becoming a viable therapeutic option for resistance pathogens in the "high-opportunity" UTI market. The analyst adds that a "clear pivotal path" for the antibiotic gives the stock price the appreciation potential.
06/19/18
06/19/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ollie's Bargain Outlet (OLLI) initiated with a Hold at Loop Capital. 2. B&G Foods (BGS) assumed with a Neutral at Piper Jaffray. 3. Iterum Therapeutics (ITRM) initiated with an Outperform at RBC Capital and Leerink while being initiated with a Buy at Needham and Guggenheim. 4. Ingersoll-Rand (IR) initiated with an Outperform at Cowen. 5. Ally Financial (ALLY) initiated with a Neutral at Nomura Instinet. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MIK

Michaels

$12.78

0.99 (8.40%)

06:59
03/20/19
03/20
06:59
03/20/19
06:59
Downgrade
Michaels rating change  »

Michaels downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVRO

Nevro

$44.76

0.37 (0.83%)

06:59
03/20/19
03/20
06:59
03/20/19
06:59
Upgrade
Nevro rating change  »

Nevro upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

UBSH

Union Bankshares

$34.56

-1.31 (-3.65%)

06:59
03/20/19
03/20
06:59
03/20/19
06:59
Initiation
Union Bankshares initiated  »

Union Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$10.63

-0.31 (-2.83%)

06:57
03/20/19
03/20
06:57
03/20/19
06:57
Periodicals
Snapchat admits age verification process is effectively useless, BI reports »

Snap's senior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

ZEAL

Zealand Pharma

$15.60

(0.00%)

06:57
03/20/19
03/20
06:57
03/20/19
06:57
Hot Stocks
Breaking Hot Stocks news story on Zealand Pharma »

Zealand Pharma AS (ADS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$43.51

-0.16 (-0.37%)

06:57
03/20/19
03/20
06:57
03/20/19
06:57
Recommendations
Smartsheet analyst commentary  »

Smartsheet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

TXRH

Texas Roadhouse

$60.46

-0.39 (-0.64%)

06:56
03/20/19
03/20
06:56
03/20/19
06:56
Upgrade
Texas Roadhouse rating change  »

Texas Roadhouse upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

, AZN

AstraZeneca

$42.87

0.29 (0.68%)

06:54
03/20/19
03/20
06:54
03/20/19
06:54
Recommendations
Bayer, AstraZeneca, Sanofi, Novartis, Merck analyst commentary  »

Bayer shares likely to…

BAYRY

Bayer

$0.00

(0.00%)

AZN

AstraZeneca

$42.87

0.29 (0.68%)

SNY

Sanofi

$45.18

0.27 (0.60%)

NVS

Novartis

$92.99

-0.205 (-0.22%)

MRK

Merck

$81.93

0.59 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 22

    Mar

  • 25

    Mar

  • 11

    Apr

  • 28

    Apr

  • 30

    Apr

  • 18

    May

  • 17

    Jun

BA

Boeing

$373.87

1.77 (0.48%)

06:51
03/20/19
03/20
06:51
03/20/19
06:51
Periodicals
Off-duty pilot saved Lion Air 737 day before fatal crash, Bloomberg reports »

An off-duty pilot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

CTXS

Citrix

$101.31

-0.24 (-0.24%)

06:51
03/20/19
03/20
06:51
03/20/19
06:51
Conference/Events
Citrix to host CEMEX Day 2019 »

CEMEX Day 2019 to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 17

    Apr

IRM

Iron Mountain

$34.51

-0.29 (-0.83%)

06:51
03/20/19
03/20
06:51
03/20/19
06:51
Hot Stocks
Iron Mountain, MakeSpace announce partnership for storage services »

MakeSpace, an on-demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$175.77

6.86 (4.06%)

06:49
03/20/19
03/20
06:49
03/20/19
06:49
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKBA

Akebia

$8.12

-0.07 (-0.85%)

06:48
03/20/19
03/20
06:48
03/20/19
06:48
Initiation
Akebia initiated  »

Citi starts Akebia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMP

JMP Group

$3.79

-0.07 (-1.81%)

06:48
03/20/19
03/20
06:48
03/20/19
06:48
Hot Stocks
JMP Group sells majority interest in JMP Credit Advisors »

JMP Group has sold a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$42.32

0.51 (1.22%)

06:47
03/20/19
03/20
06:47
03/20/19
06:47
Hot Stocks
Pfizer secures exclusive option to acquire Vivet Therapeutics »

Vivet Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 30

    Apr

  • 18

    May

FDX

FedEx

$181.50

-0.92 (-0.50%)

06:46
03/20/19
03/20
06:46
03/20/19
06:46
Recommendations
FedEx analyst commentary  »

FedEx remains 'story…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 02

    Apr

  • 25

    Jun

ENV

Envestnet

$66.69

0.29 (0.44%)

06:45
03/20/19
03/20
06:45
03/20/19
06:45
Downgrade
Envestnet rating change  »

Envestnet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

06:45
03/20/19
03/20
06:45
03/20/19
06:45
General news
Breaking General news story  »

Week of 3/15 MBA Mortgage…

ZTS

Zoetis

$98.72

0.95 (0.97%)

06:43
03/20/19
03/20
06:43
03/20/19
06:43
Initiation
Zoetis initiated  »

Zoetis resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

$204.57

0.855 (0.42%)

06:43
03/20/19
03/20
06:43
03/20/19
06:43
Conference/Events
Tyler Technologies management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

MO

Altria Group

$56.01

-1.295 (-2.26%)

06:42
03/20/19
03/20
06:42
03/20/19
06:42
Periodicals
FDA commissioner calls meeting with Altria, Juul 'difficult', CNBC reports »

Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 16

    May

TDC

Teradata

$48.33

0.58 (1.21%)

06:42
03/20/19
03/20
06:42
03/20/19
06:42
Downgrade
Teradata rating change  »

Citi downgrades Teradata…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

STL

Sterling Bancorp

$19.86

-0.39 (-1.93%)

06:40
03/20/19
03/20
06:40
03/20/19
06:40
Conference/Events
Sterling Bancorp management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

  • 18

    Jun

  • 19

    Jun

ELAN

Elanco

$33.00

1.36 (4.30%)

, ZTS

Zoetis

$98.72

0.95 (0.97%)

06:39
03/20/19
03/20
06:39
03/20/19
06:39
Initiation
Elanco, Zoetis initiated  »

Elanco resumed with a…

ELAN

Elanco

$33.00

1.36 (4.30%)

ZTS

Zoetis

$98.72

0.95 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

ROK

Rockwell Automation

$178.71

-2.02 (-1.12%)

06:38
03/20/19
03/20
06:38
03/20/19
06:38
Downgrade
Rockwell Automation rating change  »

Rockwell Automation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.